Susan McGowan, 58, died in September after taking two doses of the new generation of weight loss jabs known as GLP-1 agonists ...
Ozempic, a drug initially used to treat type 2 diabetes, is gaining attention for its weight loss benefits and potential to reduce Alzheimer's risk. H ...